Title : Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT.

Pub. Date : 2021

PMID : 33995632






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT. lenvatinib AKT serine/threonine kinase 1 Homo sapiens
2 Treatment with lenvatinib decreased the expression of MMP-2, CEMIP, CDK2, CDK4 and cyclin D1, and increased the expression of cleaved caspase-9, which was mediated by the inactivation of the PI3K/AKT pathway in vitro. lenvatinib AKT serine/threonine kinase 1 Homo sapiens
3 Besides, Lenvatinib suppressed GBC cell growth in vivo by targeting p-AKT. lenvatinib AKT serine/threonine kinase 1 Homo sapiens